{"id":"W3115410759","doi":"10.1053/j.gastro.2020.12.031","title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","year":2021,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2666,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Celgene; Biogen; Janssen Pharmaceuticals; Gilead Sciences; Medtronic; Amgen; Pfizer; Shire; Bristol-Myers Squibb; Roche; Meso Scale Diagnostics; Takeda Pharmaceutical Company; AbbVie; Merck","keywords":"STRIDE; Medicine; Physical medicine and rehabilitation; Disease; Inflammatory bowel disease; Intensive care medicine; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}